188 related articles for article (PubMed ID: 27654264)
21. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
Pai HC; Kumar S; Shen CC; Liou JP; Pan SL; Teng CM
PLoS One; 2015; 10(4):e0123819. PubMed ID: 25874627
[TBL] [Abstract][Full Text] [Related]
22. Valproic acid resensitizes cisplatin-resistant ovarian cancer cells.
Lin CT; Lai HC; Lee HY; Lin WH; Chang CC; Chu TY; Lin YW; Lee KD; Yu MH
Cancer Sci; 2008 Jun; 99(6):1218-26. PubMed ID: 18429963
[TBL] [Abstract][Full Text] [Related]
23. Effects of valproic acid on proliferation, apoptosis, angiogenesis and metastasis of ovarian cancer in vitro and in vivo.
Shan Z; Feng-Nian R; Jie G; Ting Z
Asian Pac J Cancer Prev; 2012; 13(8):3977-82. PubMed ID: 23098503
[TBL] [Abstract][Full Text] [Related]
24. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
25. Valproic Acid Promotes Apoptosis and Cisplatin Sensitivity Through Downregulation of H19 Noncoding RNA in Ovarian A2780 Cells.
Sajadpoor Z; Amini-Farsani Z; Teimori H; Shamsara M; Sangtarash MH; Ghasemi-Dehkordi P; Yadollahi F
Appl Biochem Biotechnol; 2018 Aug; 185(4):1132-1144. PubMed ID: 29468525
[TBL] [Abstract][Full Text] [Related]
26. Synergistic effect of piperine and paclitaxel on cell fate via cyt-c, Bax/Bcl-2-caspase-3 pathway in ovarian adenocarcinomas SKOV-3 cells.
Pal MK; Jaiswar SP; Srivastav AK; Goyal S; Dwivedi A; Verma A; Singh J; Pathak AK; Sankhwar PL; Ray RS
Eur J Pharmacol; 2016 Nov; 791():751-762. PubMed ID: 27756602
[TBL] [Abstract][Full Text] [Related]
27. The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer.
Helland Ø; Popa M; Bischof K; Gjertsen BT; McCormack E; Bjørge L
PLoS One; 2016; 11(6):e0158208. PubMed ID: 27352023
[TBL] [Abstract][Full Text] [Related]
28. Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis.
Takai N; Kawamata N; Gui D; Said JW; Miyakawa I; Koeffler HP
Cancer; 2004 Dec; 101(12):2760-70. PubMed ID: 15536623
[TBL] [Abstract][Full Text] [Related]
29. [Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].
Zhao D; Zhang W; Li XG; Wang XB; Zhang LF; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):193-8. PubMed ID: 21575453
[TBL] [Abstract][Full Text] [Related]
30. Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells.
Atmaca H; Gorumlu G; Karaca B; Degirmenci M; Tunali D; Cirak Y; Purcu DU; Uzunoglu S; Karabulut B; Sanli UA; Uslu R
Eur Cytokine Netw; 2009 Sep; 20(3):121-30. PubMed ID: 19825521
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
[TBL] [Abstract][Full Text] [Related]
32. Valproic acid increases the in vitro effects of nitrosureas on human glioma cell lines.
Ciusani E; Balzarotti M; Calatozzolo C; de Grazia U; Boiardi A; Salmaggi A; Croci D
Oncol Res; 2007; 16(10):453-63. PubMed ID: 18196869
[TBL] [Abstract][Full Text] [Related]
33. MRI reveals the in vivo cellular and vascular response to BEZ235 in ovarian cancer xenografts with different PI3-kinase pathway activity.
Cebulla J; Huuse EM; Pettersen K; van der Veen A; Kim E; Andersen S; Prestvik WS; Bofin AM; Pathak AP; Bjørkøy G; Bathen TF; Moestue SA
Br J Cancer; 2015 Feb; 112(3):504-13. PubMed ID: 25535727
[TBL] [Abstract][Full Text] [Related]
34. Effects of valproic acid and levetiracetam on viability and cell cycle regulatory genes expression in the OVCAR-3 cell line.
Kwiecińska P; Taubøll E; Gregoraszczuk EL
Pharmacol Rep; 2012; 64(1):157-65. PubMed ID: 22580532
[TBL] [Abstract][Full Text] [Related]
35. Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial.
Fushida S; Kinoshita J; Kaji M; Oyama K; Hirono Y; Tsukada T; Fujimura T; Ohta T
Drug Des Devel Ther; 2016; 10():2353-8. PubMed ID: 27524882
[TBL] [Abstract][Full Text] [Related]
36. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
[TBL] [Abstract][Full Text] [Related]
37. Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells.
Aztopal N; Erkisa M; Erturk E; Ulukaya E; Tokullugil AH; Ari F
Chem Biol Interact; 2018 Jan; 280():51-58. PubMed ID: 29225137
[TBL] [Abstract][Full Text] [Related]
38. Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies.
Qian X; LaRochelle WJ; Ara G; Wu F; Petersen KD; Thougaard A; Sehested M; Lichenstein HS; Jeffers M
Mol Cancer Ther; 2006 Aug; 5(8):2086-95. PubMed ID: 16928830
[TBL] [Abstract][Full Text] [Related]
39. Evaluation Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus in Combination With Anticancer Drugs in Human Cancer Orthotopic Mouse Models.
Burney M; Mathew L; Gaikwad A; Nugent EK; Gonzalez AO; Smith JA
Integr Cancer Ther; 2018 Sep; 17(3):755-761. PubMed ID: 29156992
[TBL] [Abstract][Full Text] [Related]
40. Antitumour effect of valproic acid against salivary gland cancer in vitro and in vivo.
Nagai H; Fujioka-Kobayashi M; Ohe G; Hara K; Takamaru N; Uchida D; Tamatani T; Fujisawa K; Miyamoto Y
Oncol Rep; 2014 Mar; 31(3):1453-8. PubMed ID: 24398788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
